An optical biosensor assay for rapid dual detection of Botulinum neurotoxins A and e

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lévêque, Christian ^a,c   Ferracci, Géraldine ^b,c   Maulet, Yves ^a,c   Mazuet, Christelle ^d   Popoff, Michel R ^d   Blanchard, Marie Pierre ^b,c   Seagar, Michael ^a,c   El Far, Oussama ^a,c  

^a Aix Marseille University   (France)

^b CNRS   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; EPITOPE; MONOCLONAL ANTIBODY;

ENZYME ACTIVATION; ENZYME SPECIFICITY; GENETIC PROCEDURES; HUMAN; IMMUNOLOGY; KINETICS; LAB ON A CHIP; MICROCHIP ANALYSIS; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; BIOSENSING TECHNIQUES; BOTULINUM TOXINS; BOTULINUM TOXINS, TYPE A; ENZYME ACTIVATION; EPITOPES; HUMANS; KINETICS; LAB-ON-A-CHIP DEVICES; MICROCHIP ANALYTICAL PROCEDURES; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 84949550381     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17953     Document Type: Article

References (30)

1. Rossetto, O., Megighian, A., Scorzeto, M. & Montecucco, C. Botulinum neurotoxins. Toxicon 67, 31-36, doi: 10.1016/j. toxicon.2013.01.017 (2013).
2. Arnon, S. S. et al. Botulinum toxin as a biological weapon: medical and public health management. Jama 285, 1059-1070 (2001).
3. Sobel, J. Botulism. Clin Infect Dis 41, 1167-1173, doi: 10.1086/444507 (2005).
4. Lindstrom, M. & Korkeala, H. Laboratory diagnostics of botulism. Clin Microbiol Rev 19, 298-314, doi: 10.1128/CMR.19.2.298-314.2006 (2006).
5. Wilder-Kofie, T. D. et al. An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection. Comp Med 61, 235-242 (2011).
6. Horowitz, B. Z. Type E botulism. Clin Toxicol (Phila) 48, 880-895, doi: 10.3109/15563650.2010.526943 (2010).
7. Sobel, J., Tucker, N., Sulka, A., McLaughlin, J. & Maslanka, S. Foodborne botulism in the United States, 1990-2000. Emerg Infect Dis 10, 1606-1611, doi: 10.3201/eid1009.030745 (2004).
8. Piazza, T. M. et al. In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood. Appl Environ Microbiol 77, 7815-7822, doi: 10.1128/AEM.06165-11 (2011).
9. Mazuet, C. et al. An Atypical Outbreak of Food-Borne Botulism Due to Clostridium botulinum Types B and E from Ham. J Clin Microbiol 53, 722-726, doi: 10.1128/jcm.02942-14 (2015).
10. Duff, J. T., Wright, G. G. & Yarinsky, A. Activation of Clostridium botulinum type E toxin by trypsin. J Bacteriol 72, 455-460 (1956).
11. Das Gupta, B. R. & Sugiyama, H. Role of a protease in natural activation of Clostridium botulinum neurotoxin. Infect Immun 6, 587-590 (1972).
12. Popoff, M. R. & Poulain, B. Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells. Toxins (Basel) 2, 683-737, doi: 10.3390/toxins2040683 (2010).
13. Tighe, A. P. & Schiavo, G. Botulinum neurotoxins: mechanism of action. Toxicon 67, 87-93, doi: 10.1016/j.toxicon.2012.11.011 (2013).
14. Purcell, A. L. & Hoard-Fruchey, H. M. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity. Anal Biochem 366, 207-217, doi: 10.1016/j.ab.2007.04.048 (2007).
15. Jones, R. G., Ochiai, M., Liu, Y., Ekong, T. & Sesardic, D. Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. J Immunol Methods 329, 92-101, doi: 10.1016/j.jim.2007.09.014 (2008).
16. Wang, D. et al. A two-stage multiplex method for quantitative analysis of botulinum neurotoxins type A, B, E, and F by MALDI-TOF mass spectrometry. Anal Chem 86, 10847-10854, doi: 10.1021/ac502948v (2014).
17. Barr, J. R. et al. Botulinum neurotoxin detection and differentiation by mass spectrometry. Emerg Infect Dis 11, 1578-1583, doi: 10.3201/eid1110.041279 (2005).
18. Gilmore, M. A. et al. Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity. Anal Biochem 413, 36-42, doi: 10.1016/j.ab.2011.01.043 (2011).
19. Park, S., Shin, Y. M., Song, J. J. & Yang, H. Facile electrochemical detection of botulinum neurotoxin type E using a two-step proteolytic cleavage. Biosens Bioelectron 72, 211-217, doi: 10.1016/j.bios.2015.05.016 (2015).
20. Leveque, C. et al. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A. Biosens Bioelectron 49, 276-281, doi: 10.1016/j.bios.2013.05.032 (2013).
21. Leveque, C. et al. Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism. Biosens Bioelectron 57, 207-212, doi: 10.1016/j.bios.2014.02.015 (2014).
22. Bravman, T. et al. Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem 358, 281-288, doi: http://dx.doi.org/10.1016/j.ab.2006.08.005 (2006).
23. Moberg, A., Lager, A., Hämäläinen, M. D. & Jarhede, T. Increased sensitivity of SPR assays in plasma through efficient parallel assay optimization. J Pharm Biomed Anal 78-79, 224-232, doi: http://dx.doi.org/10.1016/j.jpba.2013.02.018 (2013).
24. Sesardic, D., Leung, T. & Gaines Das, R. Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin. Biologicals 31, 265-276 (2003).
25. Björnstad, K. et al. Validation of the Endopep-MS method for qualitative detection of active botulinum neurotoxins in human and chicken serum. Anal Bioanal Chem 406, 7149-7161, doi: 10.1007/s00216-014-8170-4 (2014).
26. Wang, D., Krilich, J., Baudys, J., Barr, J. R. & Kalb, S. R. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay. Anal Biochem 468, 15-21, doi: http://dx.doi.org/10.1016/j.ab.2014.08.026 (2015).
27. Di Giovanni, J. et al. V-ATPase membrane sector associates with synaptobrevin to modulate neurotransmitter release. Neuron 67, 268-279, doi: 10.1016/j.neuron.2010.06.024 (2010).
28. Couesnon, A., Raffestin, S. & Popoff, M. R. Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR. Microbiology 152, 759-770, doi: 10.1099/mic.0.28561-0 (2006).
29. Marconi, S. et al. A protein chip membrane-capture assay for botulinum neurotoxin activity. Toxicology and applied pharmacology 233, 439-446 (2008).
30. Mazuet, C., Ezan, E., Volland, H., Popoff, M. R. & Becher, F. Toxin detection in patients' sera by mass spectrometry during two outbreaks of type A Botulism in France. Journal of clinical microbiology 50, 4091-4094 (2012).